|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/21 Allscripts Healthcare Soluti… Inc 10-K 12/31/20 165:35M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 3.14M
2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 56K
3: EX-10.5 Material Contract HTML 243K
4: EX-10.6 Material Contract HTML 256K
5: EX-21.1 Subsidiaries List HTML 62K
6: EX-23.1 Consent of Expert or Counsel HTML 45K
7: EX-31.1 Certification -- §302 - SOA'02 HTML 52K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 52K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 48K
16: R1 Document and Entity Information HTML 112K
17: R2 Consolidated Balance Sheets HTML 172K
18: R3 Consolidated Balance Sheets (Parenthetical) HTML 73K
19: R4 Consolidated Statements of Operations HTML 184K
20: R5 Consolidated Statements of Comprehensive Income HTML 86K
21: R6 Consolidated Statements of Stockholders' Equity HTML 155K
22: R7 Consolidated Statements of Stockholders' Equity HTML 48K
(Parenthetical)
23: R8 Consolidated Statements of Cash Flows HTML 187K
24: R9 Basis of Presentation and Significant Accounting HTML 128K
Policies
25: R10 Revenue from Contracts with Customers HTML 292K
26: R11 Accounts Receivables HTML 62K
27: R12 Leases HTML 121K
28: R13 Business Combinations and Divestitures HTML 163K
29: R14 Fair Value Measurements and Other Investments HTML 287K
30: R15 Fixed Assets HTML 96K
31: R16 Goodwill and Intangible Assets HTML 249K
32: R17 Asset Impairment Charges HTML 72K
33: R18 Debt HTML 240K
34: R19 Income Taxes HTML 390K
35: R20 Stock Award Plan HTML 262K
36: R21 Stockholders' Equity HTML 65K
37: R22 Earnings (Loss) Per Share HTML 223K
38: R23 Accumulated Other Comprehensive Loss HTML 248K
39: R24 Derivative Financial Instruments HTML 201K
40: R25 Commitments HTML 60K
41: R26 Discontinued Operations HTML 336K
42: R27 Business Segments HTML 155K
43: R28 Supplemental Disclosures HTML 170K
44: R29 Geographic Information HTML 98K
45: R30 Contingencies HTML 53K
46: R31 Quarterly Financial Information (Unaudited) HTML 500K
47: R32 Schedule II-Valuation and Qualifying Accounts HTML 87K
48: R33 Basis of Presentation and Significant Accounting HTML 206K
Policies (Policies)
49: R34 Basis of Presentation and Significant Accounting HTML 98K
Policies (Tables)
50: R35 Revenue from Contracts with Customers (Tables) HTML 250K
51: R36 Accounts Receivables (Tables) HTML 61K
52: R37 Leases (Tables) HTML 123K
53: R38 Business Combinations and Divestitures (Tables) HTML 154K
54: R39 Fair Value Measurements and Other Investments HTML 286K
(Tables)
55: R40 Fixed Assets (Tables) HTML 97K
56: R41 Goodwill and Intangible Assets (Tables) HTML 246K
57: R42 Asset Impairment Charges (Tables) HTML 67K
58: R43 Debt (Tables) HTML 214K
59: R44 Income Taxes (Tables) HTML 396K
60: R45 Stock Award Plan (Tables) HTML 258K
61: R46 Earnings (Loss) Per Share (Tables) HTML 224K
62: R47 Accumulated Other Comprehensive Loss (Tables) HTML 249K
63: R48 Derivative Financial Instruments (Tables) HTML 200K
64: R49 Commitments (Tables) HTML 58K
65: R50 Discontinued Operations (Tables) HTML 338K
66: R51 Business Segments (Tables) HTML 146K
67: R52 Supplemental Disclosures (Tables) HTML 175K
68: R53 Geographic Information (Tables) HTML 101K
69: R54 Quarterly Financial Information (Unaudited) HTML 500K
(Tables)
70: R55 Basis of Presentation and Significant Accounting HTML 92K
Policies - Additional Information (Detail)
71: R56 Basis of Presentation and Significant Accounting HTML 52K
Policies - Unamortized Balances of Capitalized
Software (Detail)
72: R57 Basis of Presentation and Significant Accounting HTML 52K
Policies - Capitalized Software Development Costs,
Write Offs and Amortization of Capitalized
Software Development Costs (Detail)
73: R58 Basis of Presentation and Significant Accounting HTML 48K
Policies - Company Contributions to Employee
Benefit Plan (Detail)
74: R59 Revenue from Contracts with Customers - Additional HTML 86K
Information (Detail)
75: R60 Revenue from Contracts with Customers - Summary of HTML 62K
Revenue Recognized on Various Performance
Obligations and Elected Accounting Expedients
(Detail)
76: R61 Revenue from Contracts with Customers - Summary of HTML 85K
Revenue by Type and Nature of Revenue Stream by
Reportable Segments (Detail)
77: R62 Revenue from Contracts with Customers - Summary of HTML 56K
Changes in Estimate of Credit Losses for Contract
Assets (Detail)
78: R63 Accounts Receivables - Additional Information HTML 52K
(Detail)
79: R64 Accounts Receivables - Schedule of Changes in HTML 56K
Estimate of Credit Losses for Trade Accounts
Receivable (Detail)
80: R65 Leases - Additional Information (Detail) HTML 53K
81: R66 Leases - Summary of Operating Costs Associated HTML 53K
with Leased Assets (Detail)
82: R67 Leases - Supplemental Information for Operating HTML 50K
Leases (Detail)
83: R68 Leases - Summary of Balance Sheet Location and HTML 56K
Balances for Operating Leases (Detail)
84: R69 Leases - Summary of Future Maturities of Lease and HTML 68K
Non-Lease Components (Detail)
85: R70 Business Combinations and Divestitures - 2020 HTML 67K
Divestitures - Additional Information (Detail)
86: R71 Business Combinations and Divestitures - 2019 HTML 64K
Business Combinations - Additional Information
(Detail)
87: R72 Business Combinations and Divestitures - HTML 71K
Acquisition of Health Grid - Additional
Information (Detail)
88: R73 Business Combinations and Divestitures - Schedule HTML 69K
of Consideration Transaction (Detail)
89: R74 Business Combinations and Divestitures - Assets HTML 86K
Acquired and Liabilities Assumed (Detail)
90: R75 Business Combinations and Divestitures - Acquired HTML 70K
Intangible Assets Amortization (Detail)
91: R76 Business Combinations and Divestitures - HTML 59K
Acquisition of Practice Fusion, Inc - Additional
Information (Detail)
92: R77 Business Combinations and Divestitures - Netsmart HTML 55K
LLC Divestiture - Additional Information (Detail)
93: R78 Business Combinations and Divestitures - Other HTML 112K
Acquisitions and Divestitures - Additional
Information (Detail)
94: R79 Fair Value Measurements and Other Investments - HTML 79K
Additional Information (Detail)
95: R80 Fair Value Measurements and Other Investments - HTML 94K
Summary of Financial Assets and Liabilities
Measured at Fair Value on Recurring Basis (Detail)
96: R81 Fair Value Measurements and Other Investments - HTML 52K
Summary of Financial Assets and Liabilities
Measured at Fair Value on Recurring Basis
(Parenthetical) (Detail)
97: R82 Fair Value Measurements and Other Investments - HTML 75K
Summary of Changes in Assets and Liabilities
Measured at Fair Value on Recurring Basis (Detail)
98: R83 Fair Value Measurements and Other Investments - HTML 54K
Summary of Changes in Assets and Liabilities
Measured at Fair Value on Recurring Basis
(Parenthetical) (Detail)
99: R84 Fair Value Measurements and Other Investments - HTML 76K
Summary of Quantitative Information About Fair
Value Measurements (Detail)
100: R85 Fair Value Measurements and Other Investments - HTML 65K
Summary of Other Equity Investments Included in
Other Assets (Detail)
101: R86 Fixed Assets - Fixed Assets (Detail) HTML 76K
102: R87 Fixed Assets - Additional Information (Detail) HTML 50K
103: R88 Fixed Assets - Depreciation and Amortization HTML 48K
Expense (Detail)
104: R89 Goodwill and Intangible Assets - Goodwill and HTML 66K
Intangible Assets (Detail)
105: R90 Goodwill and Intangible Assets - Additional HTML 69K
Information (Detail)
106: R91 Goodwill and Intangible Assets - Changes in HTML 68K
Carrying Amount of Goodwill (Detail)
107: R92 Goodwill and Intangible Assets - Amortization HTML 53K
Expense Related to Intangible Assets (Detail)
108: R93 Goodwill and Intangible Assets - Future HTML 62K
Amortization Expense for Intangible Assets
(Detail)
109: R94 Asset Impairment Charges - Additional Information HTML 98K
(Detail)
110: R95 Asset Impairment Charges - Summary of Non-Cash HTML 54K
Asset Impairment Charges (Detail)
111: R96 Debt - Debt Outstanding Excluding Lease HTML 73K
Obligations (Detail)
112: R97 Debt - Debt Outstanding Excluding Lease HTML 58K
Obligations (Parenthetical) (Detail)
113: R98 Debt - Interest Expense (Detail) HTML 58K
114: R99 Debt - Interest Expense Related to 0.875% HTML 54K
Convertible Senior Notes and 1.25% Cash
Convertible Senior Notes (Detail)
115: R100 Debt - Additional Information (Detail) HTML 317K
116: R101 Debt - Summary of Future Debt Payments (Detail) HTML 67K
117: R102 Income Taxes - Geographic Breakdown of Loss From HTML 57K
Continuing Operations Before Income Tax Benefits
(Detail)
118: R103 Income Taxes - Components of Benefit for Income HTML 76K
Taxes (Detail)
119: R104 Income Taxes - Additional Information (Detail) HTML 108K
120: R105 Income Taxes - Taxes Computed at Statutory Federal HTML 100K
Income Tax Rate Reconciled to Provision for Income
Taxes (Detail)
121: R106 Income Taxes - Components of Deferred Tax Assets HTML 85K
and Liabilities (Detail)
122: R107 Income Taxes - Deferred Tax Assets (Liabilities) HTML 52K
Classified in Consolidated Balance Sheets (Detail)
123: R108 Income Taxes - Change in the Amount of HTML 59K
Unrecognized Tax Benefits (Detail)
124: R109 Income Taxes - Recognized Interest and Penalties HTML 48K
Related to Uncertain Tax Positions (Detail)
125: R110 Income Taxes - Amount of Interest and Penalties HTML 48K
Included in Consolidated Balance Sheets (Detail)
126: R111 Stock Award Plan - Stock-Based Compensation HTML 61K
Expense (Detail)
127: R112 Stock Award Plan - Additional Information (Detail) HTML 102K
128: R113 Stock Award Plan - Activity for Restricted Stock HTML 71K
Units (Detail)
129: R114 Stock Award Plan - Stock Options Outstanding HTML 75K
(Detail)
130: R115 Stock Award Plan - Stock Option Activity (Detail) HTML 51K
131: R116 Stockholders' Equity - Additional Information HTML 153K
(Detail)
132: R117 Earnings (Loss) Per Share - Calculations of HTML 132K
Earnings (Loss) Per Share (Detail)
133: R118 Earnings (Loss) Per Share - Anti-Dilutive Stock HTML 48K
Options, Restricted Stock Unit Awards and Warrants
Excluded from Computation of Diluted Earnings
(Loss) Per Share (Detail)
134: R119 Accumulated Other Comprehensive Loss - Components HTML 74K
of Accumulated Other Comprehensive Loss (Detail)
135: R120 Accumulated Other Comprehensive Loss - Components HTML 54K
of Accumulated Other Comprehensive Loss
(Parenthetical) (Detail)
136: R121 Accumulated Other Comprehensive Loss - Income Tax HTML 94K
Effects Related to Components of Other
Comprehensive Loss (Detail)
137: R122 Accumulated Other Comprehensive Loss - Income Tax HTML 49K
Effects Related to Components of Other
Comprehensive Loss (Parenthetical) (Detail)
138: R123 Derivative Financial Instruments - Fair Value and HTML 68K
Balance Sheet Locations - (Detail)
139: R124 Derivative Financial Instruments - Additional HTML 90K
Information (Detail)
140: R125 Derivative Financial Instruments - Derivatives HTML 61K
Instruments Designated as Cash Flow Hedges -
(Detail)
141: R126 Derivative Financial Instruments - Net Impact of HTML 53K
Changes in Fair Value of Call Option and Embedded
Cash Conversion Option - (Detail)
142: R127 Commitments - Additional Information (Detail) HTML 49K
143: R128 Commitments - Summary of Expense Incurred under HTML 53K
Atos Agreement (Detail)
144: R129 Discontinued Operations - Additional Information HTML 84K
(Detail)
145: R130 Discontinued Operations - Summary of Major Classes HTML 118K
of Assets and Liabilities as Reported on
Consolidated Balance Sheets (Detail)
146: R131 Discontinued Operations - Summary of Major Classes HTML 54K
of Assets and Liabilities as Reported on
Consolidated Balance Sheets (Parenthetical)
(Detail)
147: R132 Discontinued Operations - Summary of Major Classes HTML 127K
of Line Items Constituting Income (Loss) of
Discontinued Operations (Detail)
148: R133 Discontinued Operations - Summary of Major Income HTML 107K
and Expense Line Items Reported in Consolidated
Statements of Operations (Detail)
149: R134 Business Segments - Additional Information HTML 50K
(Detail)
150: R135 Business Segments - Revenues and Income (Loss) HTML 75K
from Operations Related to Segment Within
Reconciliation to Consolidated Amounts (Detail)
151: R136 Supplemental Disclosures - Supplemental HTML 71K
Disclosures (Detail)
152: R137 Supplemental Disclosures - Accrued Expenses HTML 58K
(Detail)
153: R138 Supplemental Disclosures - Additional Information HTML 47K
(Detail)
154: R139 Supplemental Disclosures - Prepaid and Other HTML 53K
Current Assets (Detail)
155: R140 Supplemental Disclosures - Other Assets (Detail) HTML 62K
156: R141 Supplemental Disclosures - Other Assets HTML 49K
(Parenthetical) (Detail)
157: R142 Geographic Information - Revenues by Geographic HTML 61K
Area (Detail)
158: R143 Geographic Information - Long-Lived Assets by HTML 59K
Geographic Area (Detail)
159: R144 Contingencies - Additional Information (Detail) HTML 57K
160: R145 Quarterly Financial Information (Unaudited) - HTML 182K
Quarterly Financial Information (Unaudited)
(Detail)
161: R146 Schedule II - Valuation and Qualifying Accounts HTML 52K
(Detail)
163: XML IDEA XML File -- Filing Summary XML 325K
15: XML XBRL Instance -- mdrx-10k_20201231_htm XML 9.53M
162: EXCEL IDEA Workbook of Financial Reports XLSX 238K
11: EX-101.CAL XBRL Calculations -- mdrx-20201231_cal XML 491K
12: EX-101.DEF XBRL Definitions -- mdrx-20201231_def XML 1.67M
13: EX-101.LAB XBRL Labels -- mdrx-20201231_lab XML 2.67M
14: EX-101.PRE XBRL Presentations -- mdrx-20201231_pre XML 2.47M
10: EX-101.SCH XBRL Schema -- mdrx-20201231 XSD 404K
164: JSON XBRL Instance as JSON Data -- MetaLinks 758± 1.26M
165: ZIP XBRL Zipped Folder -- 0001564590-21-009410-xbrl Zip 787K
EXHIBIT 21.1
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
|
|
|
|
|
Subsidiary |
|
Jurisdiction or |
|
Allscripts Holdings, LLC |
|
Delaware |
|
|
|
|
|
Allscripts Holdings 2, LLC |
|
Delaware |
|
|
|
|
|
Coniston Exchange, LLC |
|
Delaware |
|
|
|
|
|
Allscripts Healthcare US, LP |
|
Delaware |
|
|
|
|
|
Allscripts Healthcare, LLC |
|
North Carolina |
|
|
|
|
|
Allscripts Managed Services, LLC |
|
Delaware |
|
|
|
|
|
Allscripts Software, LLC |
|
Delaware |
|
|
|
|
|
California Healthcare Medical Billing, LLC |
|
California |
|
|
|
|
|
Allscripts Analytics, LLC |
|
Delaware |
|
|
|
|
|
Allscripts Next, LLC |
|
Delaware |
|
|
|
|
|
2bPrecise, LLC |
|
Delaware |
|
|
|
|
|
2bPrecise Ltd. |
|
Israel |
|
|
|
|
|
PF2 EIS LLC |
|
Delaware |
|
|
|
|
|
Practice Fusion, Inc. |
|
Delaware |
|
|
|
|
|
Ringadoc, Inc. |
|
Delaware |
|
|
|
|
|
Evalytica, LLC |
|
California |
|
|
|
|
|
Health Grid Holding Company LLC |
|
Delaware |
|
|
|
|
|
HealthGrid Coordinated Care Solutions LLC. |
|
Delaware |
|
|
|
|
|
Health Grid, LLC |
|
Florida |
|
|
|
|
|
Mahathi Software LLC. |
|
Florida |
|
|
|
|
|
PF2 Enterprise Information Solutions Canada |
|
Canada |
|
|
|
|
|
Allscripts Canada Corporation |
|
Canada |
|
|
|
|
|
Allscripts Healthcare IT (Canada) Corporation (f/k/a NantHealth Canada, Inc.) |
|
Canada |
|
|
|
|
|
Allscripts Healthcare International Holdings, LLC |
|
Delaware |
|
|
|
|
|
Allscripts (Mauritius) Limited |
|
Mauritius |
|
|
|
|
|
Allscripts (India) LLP |
|
India |
|
|
|
|
|
Nant Health Technologies Private Limited |
|
India |
|
|
|
|
|
Allscripts Healthcare IT (Malaysia) SDN. BHD. |
|
Malaysia |
|
|
|
|
|
Allscripts Healthcare IT (Singapore) PTE. LTD. |
|
Singapore |
|
|
|
|
|
Allscripts Healthcare IT (Australia) PTY. LTD. |
|
Australia |
|
|
|
|
|
Allscripts Healthcare (IT) UK LTD. |
|
United Kingdom |
|
|
|
|
|
Allscripts (United Kingdom) Limited |
|
United Kingdom |
|
|
|
|
|
dbMotion, Ltd. |
|
Israel |
|
|
|
|
|
dbMotion, Inc. |
|
Delaware |
|
|
|
|
|
Allscripts CV |
|
Netherlands |
|
|
|
|
|
Allscripts BV |
|
Netherlands |
|
|
|
|
|
Allscripts Healthcare IT (Mauritius) Limited |
|
Mauritius |
|
|
|
|
|
Core Medical Solutions Holdings PTY LTD. |
|
Australia |
|
|
|
|
|
Core Medical Solutions PTY. LTD. |
|
Australia |
|
|
|
|
|
Pulse8, LLC |
|
Maryland |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/22 Veradigm Inc. 10-K/A 12/31/21 12:4M Donnelley … Solutions/FA 2/25/22 Veradigm Inc. 10-K 12/31/21 150:28M Donnelley … Solutions/FA |